Similar articles

• Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.

  Hansen ML, Sørensen R, Clausen MT, Fog-Petersen ML, Raunsø J, Gadsbøll N, Gislason GH, Folke F, Andersen SS, Schramm TK, Abildstrøm SZ, Poulsen HE, Køber L, Torp-Pedersen C. Hansen ML, et al. Arch Intern Med. 2010 Sep 13;170(16):1433-41. doi: 10.1001/archinternmed.2010.271. Arch Intern Med. 2010. PMID: 20837828
• Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.

  Rubboli A, Halperin JL. Rubboli A, et al. Thromb Haemost. 2008 Nov;100(5):752-3. Thromb Haemost. 2008. PMID: 18989515 No abstract available.
• Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.

  Roldán V, Marín F. Roldán V, et al. Thromb Haemost. 2008 Nov;100(5):754-5. Thromb Haemost. 2008. PMID: 18989516 No abstract available.
• Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?

  Hermosillo AJ, Spinler SA. Hermosillo AJ, et al. Ann Pharmacother. 2008 Jun;42(6):790-805. doi: 10.1345/aph.1K591. Epub 2008 May 13. Ann Pharmacother. 2008. PMID: 18477734 Review.
• Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.

  Garwood CL, Corbett TL. Garwood CL, et al. Ann Pharmacother. 2008 Apr;42(4):523-32. doi: 10.1345/aph.1K498. Epub 2008 Mar 11. Ann Pharmacother. 2008. PMID: 18334606 Review.